XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Employees
Common Stock
Executive Officer [Member]
Common Stock
Consultants
Common Stock
Director
Common Stock
Paid-In Capital [Member]
Employees
Paid-In Capital [Member]
Executive Officer [Member]
Paid-In Capital [Member]
Consultants
Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Noncontrolling Interest [Member]
Employees
Executive Officer [Member]
Consultants
Total
Balances at Dec. 31, 2021         $ 20,000       $ 103,039,000 $ (28,779,000) $ 662,000       $ 74,942,000
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 30,000           30,000
Net income (loss)                   (3,487,000) (252,000)       (3,739,000)
Balances at Mar. 31, 2022         $ 20,000       103,069,000 (32,266,000) 410,000       71,233,000
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Balances at Dec. 31, 2021         $ 20,000       103,039,000 (28,779,000) 662,000       74,942,000
Balances (in shares) at Dec. 31, 2021         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             1,020,000
Balances at Sep. 30, 2022         $ 20,000       103,541,000 (26,818,000) (279,000)       76,464,000
Balances (in shares) at Sep. 30, 2022         19,624,860                    
Balances at Mar. 31, 2022         $ 20,000       103,069,000 (32,266,000) 410,000       71,233,000
Balances (in shares) at Mar. 31, 2022         19,571,119                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 402,000           402,000
Shares issued related to/in connection with stock grant           $ 50,000 $ 281,000         $ 50,000 $ 281,000    
Shares issued related to/in connection with stock grant 33,557 178,727   50,000                      
Shares issued to consultant in connection with Isaac Mizrahi sale transaction               $ 33,000 97,000         $ 33,000 97,000
Shares issued to consultant in connection with Isaac Mizrahi sale transaction     20,064   65,275                    
Shares repurchased in exchange for withholding taxes           $ (357,000) $ (85,000)         $ (357,000) $ (85,000)    
Shares repurchased in exchange for withholding taxes (in shares) (240,000) (53,882)                          
Net income (loss)                   9,490,000 (301,000)       9,189,000
Balances at Jun. 30, 2022         $ 20,000       103,490,000 (22,776,000) 109,000       80,843,000
Balances (in shares) at Jun. 30, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 51,000           51,000
Net income (loss)                   (4,042,000) (388,000)       (4,430,000)
Balances at Sep. 30, 2022         $ 20,000       103,541,000 (26,818,000) (279,000)       76,464,000
Balances (in shares) at Sep. 30, 2022         19,624,860                    
Balances at Dec. 31, 2022         $ 20,000       103,592,000 (32,797,000) (676,000)       70,139,000
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 51,000           51,000
Shares issued related to/in connection with stock grant               6,000           6,000  
Shares issued related to/in connection with stock grant     8,334                        
Net income (loss)                   (5,643,000) (295,000)       (5,938,000)
Balances at Mar. 31, 2023         $ 20,000       103,649,000 (38,440,000) (971,000)       64,258,000
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Balances at Dec. 31, 2022         $ 20,000       103,592,000 (32,797,000) (676,000)       70,139,000
Balances (in shares) at Dec. 31, 2022         19,624,860                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss)                             (15,042,000)
Balances at Sep. 30, 2023         $ 20,000       103,804,000 (47,052,000) (1,463,000)       55,309,000
Balances (in shares) at Sep. 30, 2023         19,800,053                    
Balances at Mar. 31, 2023         $ 20,000       103,649,000 (38,440,000) (971,000)       64,258,000
Balances (in shares) at Mar. 31, 2023         19,633,194                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 27,000           27,000
Shares issued related to/in connection with stock grant               $ 39,000           $ 39,000  
Shares issued related to/in connection with stock grant     58,334                        
Shares issued on exercise of stock options, net (in shares)         9,128                    
Net income (loss)                   (3,468,000) (233,000)       (3,701,000)
Balances at Jun. 30, 2023         $ 20,000       103,715,000 (41,908,000) (1,204,000)       60,623,000
Balances (in shares) at Jun. 30, 2023         19,700,656                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Compensation expense related to stock options and restricted stock                 36,000           36,000
Shares issued related to/in connection with stock grant           10,000           10,000      
Shares issued in connection to restricted stock grants $ 7,300                            
Shares issued in connection with restricted stock grants (in shares)       40,000                      
Shares issued on exercise of stock options, net                 27,000           27,000
Shares issued on exercise of stock options, net (in shares)         52,097                    
Net income (loss)                   (5,144,000) (259,000)       (5,403,000)
Balances at Sep. 30, 2023         $ 20,000       $ 103,804,000 $ (47,052,000) $ (1,463,000)       $ 55,309,000
Balances (in shares) at Sep. 30, 2023         19,800,053